Taken together, we demonstrated that the tumor suppressor SH2D4A is linking STAT3 nuclear and mitochondrial functions, and inhibition of PHB-binding may have therapeutic effects in tumor cells with STAT3 activation. The gene discussed is PHB1; the disease is neoplasm.